sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global AT1 Receptor Antagonists Market Growth 2018-2023

Global AT1 Receptor Antagonists Market Growth 2018-2023

Category : Pharmaceuticals and Healthcare LP INFORMATION Pages :159
Published Date : 2018-11-01

 

AT1 receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II. According to this study, over the next five years the AT1 Receptor Antagonists market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in AT1 Receptor Antagonists business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of AT1 Receptor Antagonists market by product type, application, key manufacturers and key regions and countries. This study considers the AT1 Receptor Antagonists value and volume generated from the sales of the following segments: Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Valsartan Telmisartan Losartan Irbesartan Azilsartan Olmesartan Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8. Hypertension Cardiovascular Diseases Kidney Diseases Other This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Spain Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3. Pfizer Novartis Merck Astra Zeneca Jhonson and Johnson Eli Lilly and Company Sanofi SA Bristol-Myers Squibb Bayer GSK Teva Pharmaceutical In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development. Research objectives To study and analyze the global AT1 Receptor Antagonists consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023. To understand the structure of AT1 Receptor Antagonists market by identifying its various subsegments. Focuses on the key global AT1 Receptor Antagonists manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the AT1 Receptor Antagonists with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of AT1 Receptor Antagonists submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents 2018-2023 Global AT1 Receptor Antagonists Consumption Market Report 1 Scope of the Report 1.1 Market Introduction 1.2 Research Objectives 1.3 Years Considered 1.4 Market Research Methodology 1.5 Economic Indicators 1.6 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global AT1 Receptor Antagonists Consumption 2013-2023 2.1.2 AT1 Receptor Antagonists Consumption CAGR by Region 2.2 AT1 Receptor Antagonists Segment by Type 2.2.1 Valsartan 2.2.2 Telmisartan 2.2.3 Losartan 2.2.4 Irbesartan 2.2.5 Azilsartan 2.2.6 Olmesartan 2.3 AT1 Receptor Antagonists Consumption by Type 2.3.1 Global AT1 Receptor Antagonists Consumption Market Share by Type (2013-2018) 2.3.2 Global AT1 Receptor Antagonists Revenue and Market Share by Type (2013-2018) 2.3.3 Global AT1 Receptor Antagonists Sale Price by Type (2013-2018) 2.4 AT1 Receptor Antagonists Segment by Application 2.4.1 Hypertension 2.4.2 Cardiovascular Diseases 2.4.3 Kidney Diseases 2.4.4 Other 2.5 AT1 Receptor Antagonists Consumption by Application 2.5.1 Global AT1 Receptor Antagonists Consumption Market Share by Application (2013-2018) 2.5.2 Global AT1 Receptor Antagonists Value and Market Share by Application (2013-2018) 2.5.3 Global AT1 Receptor Antagonists Sale Price by Application (2013-2018) 3 Global AT1 Receptor Antagonists by Players 3.1 Global AT1 Receptor Antagonists Sales Market Share by Players 3.1.1 Global AT1 Receptor Antagonists Sales by Players (2016-2018) 3.1.2 Global AT1 Receptor Antagonists Sales Market Share by Players (2016-2018) 3.2 Global AT1 Receptor Antagonists Revenue Market Share by Players 3.2.1 Global AT1 Receptor Antagonists Revenue by Players (2016-2018) 3.2.2 Global AT1 Receptor Antagonists Revenue Market Share by Players (2016-2018) 3.3 Global AT1 Receptor Antagonists Sale Price by Players 3.4 Global AT1 Receptor Antagonists Manufacturing Base Distribution, Sales Area, Product Types by Players 3.4.1 Global AT1 Receptor Antagonists Manufacturing Base Distribution and Sales Area by Players 3.4.2 Players AT1 Receptor Antagonists Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 AT1 Receptor Antagonists by Regions 4.1 AT1 Receptor Antagonists by Regions 4.1.1 Global AT1 Receptor Antagonists Consumption by Regions 4.1.2 Global AT1 Receptor Antagonists Value by Regions 4.2 Americas AT1 Receptor Antagonists Consumption Growth 4.3 APAC AT1 Receptor Antagonists Consumption Growth 4.4 Europe AT1 Receptor Antagonists Consumption Growth 4.5 Middle East & Africa AT1 Receptor Antagonists Consumption Growth 5 Americas 5.1 Americas AT1 Receptor Antagonists Consumption by Countries 5.1.1 Americas AT1 Receptor Antagonists Consumption by Countries (2013-2018) 5.1.2 Americas AT1 Receptor Antagonists Value by Countries (2013-2018) 5.2 Americas AT1 Receptor Antagonists Consumption by Type 5.3 Americas AT1 Receptor Antagonists Consumption by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Key Economic Indicators of Few Americas Countries 6 APAC 6.1 APAC AT1 Receptor Antagonists Consumption by Countries 6.1.1 APAC AT1 Receptor Antagonists Consumption by Countries (2013-2018) 6.1.2 APAC AT1 Receptor Antagonists Value by Countries (2013-2018) 6.2 APAC AT1 Receptor Antagonists Consumption by Type 6.3 APAC AT1 Receptor Antagonists Consumption by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 Key Economic Indicators of Few APAC Countries 7 Europe 7.1 Europe AT1 Receptor Antagonists by Countries 7.1.1 Europe AT1 Receptor Antagonists Consumption by Countries (2013-2018) 7.1.2 Europe AT1 Receptor Antagonists Value by Countries (2013-2018) 7.2 Europe AT1 Receptor Antagonists Consumption by Type 7.3 Europe AT1 Receptor Antagonists Consumption by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 7.9 Spain 7.10 Key Economic Indicators of Few Europe Countries 8 Middle East & Africa 8.1 Middle East & Africa AT1 Receptor Antagonists by Countries 8.1.1 Middle East & Africa AT1 Receptor Antagonists Consumption by Countries (2013-2018) 8.1.2 Middle East & Africa AT1 Receptor Antagonists Value by Countries (2013-2018) 8.2 Middle East & Africa AT1 Receptor Antagonists Consumption by Type 8.3 Middle East & Africa AT1 Receptor Antagonists Consumption by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.2 AT1 Receptor Antagonists Distributors 10.3 AT1 Receptor Antagonists Customer 11 Global AT1 Receptor Antagonists Market Forecast 11.1 Global AT1 Receptor Antagonists Consumption Forecast (2018-2023) 11.2 Global AT1 Receptor Antagonists Forecast by Regions 11.2.1 Global AT1 Receptor Antagonists Forecast by Regions (2018-2023) 11.2.2 Global AT1 Receptor Antagonists Value Forecast by Regions (2018-2023) 11.2.3 Americas Consumption Forecast 11.2.4 APAC Consumption Forecast 11.2.5 Europe Consumption Forecast 11.2.6 Middle East & Africa Consumption Forecast 11.3 Americas Forecast by Countries 11.3.1 United States Market Forecast 11.3.2 Canada Market Forecast 11.3.3 Mexico Market Forecast 11.3.4 Brazil Market Forecast 11.4 APAC Forecast by Countries 11.4.1 China Market Forecast 11.4.2 Japan Market Forecast 11.4.3 Korea Market Forecast 11.4.4 Southeast Asia Market Forecast 11.4.5 India Market Forecast 11.4.6 Australia Market Forecast 11.5 Europe Forecast by Countries 11.5.1 Germany Market Forecast 11.5.2 France Market Forecast 11.5.3 UK Market Forecast 11.5.4 Italy Market Forecast 11.5.5 Russia Market Forecast 11.5.6 Spain Market Forecast 11.6 Middle East & Africa Forecast by Countries 11.6.1 Egypt Market Forecast 11.6.2 South Africa Market Forecast 11.6.3 Israel Market Forecast 11.6.4 Turkey Market Forecast 11.6.5 GCC Countries Market Forecast 11.7 Global AT1 Receptor Antagonists Forecast by Type 11.8 Global AT1 Receptor Antagonists Forecast by Application 12 Key Players Analysis 12.1 Pfizer 12.1.1 Company Details 12.1.2 AT1 Receptor Antagonists Product Offered 12.1.3 Pfizer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.1.4 Main Business Overview 12.1.5 Pfizer News 12.2 Novartis 12.2.1 Company Details 12.2.2 AT1 Receptor Antagonists Product Offered 12.2.3 Novartis AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.2.4 Main Business Overview 12.2.5 Novartis News 12.3 Merck 12.3.1 Company Details 12.3.2 AT1 Receptor Antagonists Product Offered 12.3.3 Merck AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.3.4 Main Business Overview 12.3.5 Merck News 12.4 Astra Zeneca 12.4.1 Company Details 12.4.2 AT1 Receptor Antagonists Product Offered 12.4.3 Astra Zeneca AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.4.4 Main Business Overview 12.4.5 Astra Zeneca News 12.5 Jhonson and Johnson 12.5.1 Company Details 12.5.2 AT1 Receptor Antagonists Product Offered 12.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.5.4 Main Business Overview 12.5.5 Jhonson and Johnson News 12.6 Eli Lilly and Company 12.6.1 Company Details 12.6.2 AT1 Receptor Antagonists Product Offered 12.6.3 Eli Lilly and Company AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.6.4 Main Business Overview 12.6.5 Eli Lilly and Company News 12.7 Sanofi SA 12.7.1 Company Details 12.7.2 AT1 Receptor Antagonists Product Offered 12.7.3 Sanofi SA AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.7.4 Main Business Overview 12.7.5 Sanofi SA News 12.8 Bristol-Myers Squibb 12.8.1 Company Details 12.8.2 AT1 Receptor Antagonists Product Offered 12.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.8.4 Main Business Overview 12.8.5 Bristol-Myers Squibb News 12.9 Bayer 12.9.1 Company Details 12.9.2 AT1 Receptor Antagonists Product Offered 12.9.3 Bayer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.9.4 Main Business Overview 12.9.5 Bayer News 12.10 GSK 12.10.1 Company Details 12.10.2 AT1 Receptor Antagonists Product Offered 12.10.3 GSK AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) 12.10.4 Main Business Overview 12.10.5 GSK News 12.11 Teva Pharmaceutical 13 Research Findings and Conclusion

Get Free Sample

List of Tables and Figures Figure Picture of AT1 Receptor Antagonists Table Product Specifications of AT1 Receptor Antagonists Figure AT1 Receptor Antagonists Report Years Considered Figure Market Research Methodology Figure Global AT1 Receptor Antagonists Consumption Growth Rate 2013-2023 (K Units) Figure Global AT1 Receptor Antagonists Value Growth Rate 2013-2023 ($ Millions) Table AT1 Receptor Antagonists Consumption CAGR by Region 2013-2023 ($ Millions) Figure Product Picture of Valsartan Table Major Players of Valsartan Figure Product Picture of Telmisartan Table Major Players of Telmisartan Figure Product Picture of Losartan Table Major Players of Losartan Figure Product Picture of Irbesartan Table Major Players of Irbesartan Figure Product Picture of Azilsartan Table Major Players of Azilsartan Figure Product Picture of Olmesartan Table Major Players of Olmesartan Table Global Consumption Sales by Type (2013-2018) Table Global AT1 Receptor Antagonists Consumption Market Share by Type (2013-2018) Figure Global AT1 Receptor Antagonists Consumption Market Share by Type (2013-2018) Table Global AT1 Receptor Antagonists Revenue by Type (2013-2018) ($ million) Table Global AT1 Receptor Antagonists Value Market Share by Type (2013-2018) ($ Millions) Figure Global AT1 Receptor Antagonists Value Market Share by Type (2013-2018) Table Global AT1 Receptor Antagonists Sale Price by Type (2013-2018) Figure AT1 Receptor Antagonists Consumed in Hypertension Figure Global AT1 Receptor Antagonists Market: Hypertension (2013-2018) (K Units) Figure Global AT1 Receptor Antagonists Market: Hypertension (2013-2018) ($ Millions) Figure Global Hypertension YoY Growth ($ Millions) Figure AT1 Receptor Antagonists Consumed in Cardiovascular Diseases Figure Global AT1 Receptor Antagonists Market: Cardiovascular Diseases (2013-2018) (K Units) Figure Global AT1 Receptor Antagonists Market: Cardiovascular Diseases (2013-2018) ($ Millions) Figure Global Cardiovascular Diseases YoY Growth ($ Millions) Figure AT1 Receptor Antagonists Consumed in Kidney Diseases Figure Global AT1 Receptor Antagonists Market: Kidney Diseases (2013-2018) (K Units) Figure Global AT1 Receptor Antagonists Market: Kidney Diseases (2013-2018) ($ Millions) Figure Global Kidney Diseases YoY Growth ($ Millions) Figure AT1 Receptor Antagonists Consumed in Other Figure Global AT1 Receptor Antagonists Market: Other (2013-2018) (K Units) Figure Global AT1 Receptor Antagonists Market: Other (2013-2018) ($ Millions) Figure Global Other YoY Growth ($ Millions) Table Global Consumption Sales by Application (2013-2018) Table Global AT1 Receptor Antagonists Consumption Market Share by Application (2013-2018) Figure Global AT1 Receptor Antagonists Consumption Market Share by Application (2013-2018) Table Global AT1 Receptor Antagonists Value by Application (2013-2018) Table Global AT1 Receptor Antagonists Value Market Share by Application (2013-2018) Figure Global AT1 Receptor Antagonists Value Market Share by Application (2013-2018) Table Global AT1 Receptor Antagonists Sale Price by Application (2013-2018) Table Global AT1 Receptor Antagonists Sales by Players (2016-2018) (K Units) Table Global AT1 Receptor Antagonists Sales Market Share by Players (2016-2018) Figure Global AT1 Receptor Antagonists Sales Market Share by Players in 2016 Figure Global AT1 Receptor Antagonists Sales Market Share by Players in 2017 Table Global AT1 Receptor Antagonists Revenue by Players (2016-2018) ($ Millions) Table Global AT1 Receptor Antagonists Revenue Market Share by Players (2016-2018) Figure Global AT1 Receptor Antagonists Revenue Market Share by Players in 2016 Figure Global AT1 Receptor Antagonists Revenue Market Share by Players in 2017 Table Global AT1 Receptor Antagonists Sale Price by Players (2016-2018) Figure Global AT1 Receptor Antagonists Sale Price by Players in 2017 Table Global AT1 Receptor Antagonists Manufacturing Base Distribution and Sales Area by Players Table Players AT1 Receptor Antagonists Products Offered Table AT1 Receptor Antagonists Concentration Ratio (CR3, CR5 and CR10) (2016-2018) Table Global AT1 Receptor Antagonists Consumption by Regions 2013-2018 (K Units) Table Global AT1 Receptor Antagonists Consumption Market Share by Regions 2013-2018 Figure Global AT1 Receptor Antagonists Consumption Market Share by Regions 2013-2018 Table Global AT1 Receptor Antagonists Value by Regions 2013-2018 ($ Millions) Table Global AT1 Receptor Antagonists Value Market Share by Regions 2013-2018 Figure Global AT1 Receptor Antagonists Value Market Share by Regions 2013-2018 Figure Americas AT1 Receptor Antagonists Consumption 2013-2018 (K Units) Figure Americas AT1 Receptor Antagonists Value 2013-2018 ($ Millions) Figure APAC AT1 Receptor Antagonists Consumption 2013-2018 (K Units) Figure APAC AT1 Receptor Antagonists Value 2013-2018 ($ Millions) Figure Europe AT1 Receptor Antagonists Consumption 2013-2018 (K Units) Figure Europe AT1 Receptor Antagonists Value 2013-2018 ($ Millions) Figure Middle East & Africa AT1 Receptor Antagonists Consumption 2013-2018 (K Units) Figure Middle East & Africa AT1 Receptor Antagonists Value 2013-2018 ($ Millions) Table Americas AT1 Receptor Antagonists Consumption by Countries (2013-2018) (K Units) Table Americas AT1 Receptor Antagonists Consumption Market Share by Countries (2013-2018) Figure Americas AT1 Receptor Antagonists Consumption Market Share by Countries in 2017 Table Americas AT1 Receptor Antagonists Value by Countries (2013-2018) ($ Millions) Table Americas AT1 Receptor Antagonists Value Market Share by Countries (2013-2018) Figure Americas AT1 Receptor Antagonists Value Market Share by Countries in 2017 Table Americas AT1 Receptor Antagonists Consumption by Type (2013-2018) (K Units) Table Americas AT1 Receptor Antagonists Consumption Market Share by Type (2013-2018) Figure Americas AT1 Receptor Antagonists Consumption Market Share by Type in 2017 Table Americas AT1 Receptor Antagonists Consumption by Application (2013-2018) (K Units) Table Americas AT1 Receptor Antagonists Consumption Market Share by Application (2013-2018) Figure Americas AT1 Receptor Antagonists Consumption Market Share by Application in 2017 Figure United States AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure United States AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Canada AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Canada AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Mexico AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Mexico AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Table APAC AT1 Receptor Antagonists Consumption by Countries (2013-2018) (K Units) Table APAC AT1 Receptor Antagonists Consumption Market Share by Countries (2013-2018) Figure APAC AT1 Receptor Antagonists Consumption Market Share by Countries in 2017 Table APAC AT1 Receptor Antagonists Value by Countries (2013-2018) ($ Millions) Table APAC AT1 Receptor Antagonists Value Market Share by Countries (2013-2018) Figure APAC AT1 Receptor Antagonists Value Market Share by Countries in 2017 Table APAC AT1 Receptor Antagonists Consumption by Type (2013-2018) (K Units) Table APAC AT1 Receptor Antagonists Consumption Market Share by Type (2013-2018) Figure APAC AT1 Receptor Antagonists Consumption Market Share by Type in 2017 Table APAC AT1 Receptor Antagonists Consumption by Application (2013-2018) (K Units) Table APAC AT1 Receptor Antagonists Consumption Market Share by Application (2013-2018) Figure APAC AT1 Receptor Antagonists Consumption Market Share by Application in 2017 Figure China AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure China AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Japan AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Japan AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Korea AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Korea AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Southeast Asia AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Southeast Asia AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure India AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure India AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Australia AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Australia AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Table Europe AT1 Receptor Antagonists Consumption by Countries (2013-2018) (K Units) Table Europe AT1 Receptor Antagonists Consumption Market Share by Countries (2013-2018) Figure Europe AT1 Receptor Antagonists Consumption Market Share by Countries in 2017 Table Europe AT1 Receptor Antagonists Value by Countries (2013-2018) ($ Millions) Table Europe AT1 Receptor Antagonists Value Market Share by Countries (2013-2018) Figure Europe AT1 Receptor Antagonists Value Market Share by Countries in 2017 Table Europe AT1 Receptor Antagonists Consumption by Type (2013-2018) (K Units) Table Europe AT1 Receptor Antagonists Consumption Market Share by Type (2013-2018) Figure Europe AT1 Receptor Antagonists Consumption Market Share by Type in 2017 Table Europe AT1 Receptor Antagonists Consumption by Application (2013-2018) (K Units) Table Europe AT1 Receptor Antagonists Consumption Market Share by Application (2013-2018) Figure Europe AT1 Receptor Antagonists Consumption Market Share by Application in 2017 Figure Germany AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Germany AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure France AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure France AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure UK AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure UK AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Italy AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Italy AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Russia AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Russia AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Spain AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Spain AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Table Middle East & Africa AT1 Receptor Antagonists Consumption by Countries (2013-2018) (K Units) Table Middle East & Africa AT1 Receptor Antagonists Consumption Market Share by Countries (2013-2018) Figure Middle East & Africa AT1 Receptor Antagonists Consumption Market Share by Countries in 2017 Table Middle East & Africa AT1 Receptor Antagonists Value by Countries (2013-2018) ($ Millions) Table Middle East & Africa AT1 Receptor Antagonists Value Market Share by Countries (2013-2018) Figure Middle East & Africa AT1 Receptor Antagonists Value Market Share by Countries in 2017 Table Middle East & Africa AT1 Receptor Antagonists Consumption by Type (2013-2018) (K Units) Table Middle East & Africa AT1 Receptor Antagonists Consumption Market Share by Type (2013-2018) Figure Middle East & Africa AT1 Receptor Antagonists Consumption Market Share by Type in 2017 Table Middle East & Africa AT1 Receptor Antagonists Consumption by Application (2013-2018) (K Units) Table Middle East & Africa AT1 Receptor Antagonists Consumption Market Share by Application (2013-2018) Figure Middle East & Africa AT1 Receptor Antagonists Consumption Market Share by Application in 2017 Figure Egypt AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Egypt AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure South Africa AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure South Africa AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Israel AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Israel AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure Turkey AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure Turkey AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Figure GCC Countries AT1 Receptor Antagonists Consumption Growth 2013-2018 (K Units) Figure GCC Countries AT1 Receptor Antagonists Value Growth 2013-2018 ($ Millions) Table AT1 Receptor Antagonists Distributors List Table AT1 Receptor Antagonists Customer List Figure Global AT1 Receptor Antagonists Consumption Growth Rate Forecast (2018-2023) (K Units) Figure Global AT1 Receptor Antagonists Value Growth Rate Forecast (2018-2023) ($ Millions) Table Global AT1 Receptor Antagonists Consumption Forecast by Countries (2018-2023) (K Units) Table Global AT1 Receptor Antagonists Consumption Market Forecast by Regions Table Global AT1 Receptor Antagonists Value Forecast by Countries (2018-2023) ($ Millions) Table Global AT1 Receptor Antagonists Value Market Share Forecast by Regions Figure Americas AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Americas AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure APAC AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure APAC AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Europe AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Europe AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Middle East & Africa AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Middle East & Africa AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure United States AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure United States AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Canada AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Canada AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Mexico AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Mexico AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Brazil AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Brazil AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure China AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure China AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Japan AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Japan AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Korea AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Korea AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Southeast Asia AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Southeast Asia AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure India AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure India AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Australia AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Australia AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Germany AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Germany AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure France AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure France AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure UK AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure UK AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Italy AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Italy AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Russia AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Russia AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Spain AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Spain AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Egypt AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Egypt AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure South Africa AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure South Africa AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Israel AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Israel AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure Turkey AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure Turkey AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Figure GCC Countries AT1 Receptor Antagonists Consumption 2018-2023 (K Units) Figure GCC Countries AT1 Receptor Antagonists Value 2018-2023 ($ Millions) Table Global AT1 Receptor Antagonists Consumption Forecast by Type (2018-2023) (K Units) Table Global AT1 Receptor Antagonists Consumption Market Share Forecast by Type (2018-2023) Table Global AT1 Receptor Antagonists Value Forecast by Type (2018-2023) ($ Millions) Table Global AT1 Receptor Antagonists Value Market Share Forecast by Type (2018-2023) Table Global AT1 Receptor Antagonists Consumption Forecast by Application (2018-2023) (K Units) Table Global AT1 Receptor Antagonists Consumption Market Share Forecast by Application (2018-2023) Table Global AT1 Receptor Antagonists Value Forecast by Application (2018-2023) ($ Millions) Table Global AT1 Receptor Antagonists Value Market Share Forecast by Application (2018-2023) Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Pfizer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Pfizer AT1 Receptor Antagonists Market Share (2016-2018) Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Novartis AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Novartis AT1 Receptor Antagonists Market Share (2016-2018) Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Merck AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Merck AT1 Receptor Antagonists Market Share (2016-2018) Table Astra Zeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Astra Zeneca AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Astra Zeneca AT1 Receptor Antagonists Market Share (2016-2018) Table Jhonson and Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Jhonson and Johnson AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Jhonson and Johnson AT1 Receptor Antagonists Market Share (2016-2018) Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Eli Lilly and Company AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Eli Lilly and Company AT1 Receptor Antagonists Market Share (2016-2018) Table Sanofi SA Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Sanofi SA AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Sanofi SA AT1 Receptor Antagonists Market Share (2016-2018) Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Bristol-Myers Squibb AT1 Receptor Antagonists Market Share (2016-2018) Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Bayer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure Bayer AT1 Receptor Antagonists Market Share (2016-2018) Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors Table GSK AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2016-2018) Figure GSK AT1 Receptor Antagonists Market Share (2016-2018) Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Get Free Sample

Related Reports

Global AT1 Receptor Antagonists Market Growth 2018-2023

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global AT1 Receptor Antagonists Market Growth 2018-2023

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global AT1 Receptor Antagonists Market Growth 2018-2023

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global AT1 Receptor Antagonists Market Growth 2018-2023

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global AT1 Receptor Antagonists Market Growth 2018-2023

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)